HTBA (HealthTech BioActives)
David Sanz Ordax serves as the Chief Financial Officer at HTBA | Health & Taste Ingredients since February 2020. Previously, David held various positions at Grupo Ferrer Internacional from September 2004 to January 2020, including Director Financiero and Responsable Control Gestión, where responsibilities included designing and establishing a previously non-existent Controlling Department. David's earlier experience includes serving as Director General Gestión and Director Financiero at Lacer, as well as Corporate Financial Controller at Mecalux Warehouse Solutions, and Auditor at Arthur Andersen & Co. David's educational background includes a Licenciatura in Ciencias Económicas from Universitat de Barcelona and a degree in Auditoría de Cuentas from ICAC.
HTBA (HealthTech BioActives)
1 followers
HTBA (HealthTech BioActives) - of The Riverside Company - is a global leader in natural flavonoids and B12 derivatives creating a measurable impact on well-being by capturing nature’s power. Leveraging over 40 years of experience in the production of Solutions for Pharmaceutical APIs, Taste Modulation, Health Functional, and Animal Nutrition, from naturally sourced materials. We are determined to support our customers with rigorous standards throughout the entire value chain, from raw materials to commercialization. At HTBA we strive to continuously formulate high standards and solutions – from our Global HQ in Barcelona, Spain and US subsidiary in Cincinnati, OH to our manufacturing facilities in Beniel, Murcia (Southern Spain). www.htba.com